Mobile Investor

 Stock Information
CLDX (NASDAQ)
Last Price: 3.62
Last Trade: 12:28 PM ET - Mar 1, 2017
Change: 0.08 up  (2.12%)
Open: 3.60
Close: 3.54
High: 3.72
Low: 3.56
52-Week High: 8.75
52-Week Low: 2.85
Volume: 1,297,935
Stock price graph
 Recent News
Feb 13, 2017
Celldex Therapeutics Announces Upcoming Investor Presentations and 2016 Year-End Call
Dec 14, 2016
Celldex Therapeutics Announces Appointment to Board of Directors
Dec 5, 2016
Theresa LaVallee, Ph.D., Joins Celldex Therapeutics' Senior Management Team
Dec 5, 2016
Celldex Presents Data on CDX-1140, a Novel CD40 Agonist Antibody for Hematologic and Solid Malignancies, at the American Society of Hematology (ASH) Annual Meeting
Nov 29, 2016
Celldex Therapeutics Completes Acquisition of Kolltan Pharmaceuticals
 Events & Presentations
Mar 14, 2017 - 4:30 PM ET
Celldex Therapeutics Year End 2016 Conference Call
Mar 7, 2017 - 9:20 AM
Cowen and Company 37th Annual Health Care Conference
 Financial Filings
Nov 7, 2016
Form 10-Q - Celldex Therapeutics, Inc.
Aug 8, 2016
Form 10-Q - Celldex Therapeutics, Inc.
May 5, 2016
Form 10-Q - Celldex Therapeutics, Inc.
Apr 21, 2016
Form DEF 14A - Celldex Therapeutics, Inc.
Feb 25, 2016
Form 10-K/A - Celldex Therapeutics, Inc.
Nov 5, 2015
Form 10-Q - Celldex Therapeutics, Inc.
This is an optimized Investor Page for viewing on your mobile devices. To view our entire Investor Relations site, click here.
© 2017 Celldex Therapeutics, Inc.